National Health Investors, Inc. (NHI)
NYSE: NHI · Real-Time Price · USD
76.62
-0.53 (-0.69%)
At close: Apr 28, 2026, 4:00 PM EDT
76.61
-0.01 (-0.01%)
After-hours: Apr 28, 2026, 4:23 PM EDT
← View all transcripts

Earnings Call: Q1 2022

May 10, 2022

Operator

Greetings, and welcome to the National Health Investors first quarter 2022 conference call. During the presentation, all participants will be in a listen-only mode. Afterwards, we will conduct a question-and-answer session. At that time, if you have a question, please press the one followed by the four on your telephone. If at any time during the conference you need to reach an operator, please press star zero. As a reminder, this conference is being recorded Tuesday, May 10, 2022. It is now my pleasure to turn the conference over to Dana Hambly. Please go ahead.

Dana Hambly
VP, Finance and Investor Relations, National Health Investors

Thank you, and welcome to the National Health Investors conference call to review the company's results for the first quarter of 2022. On the call today are Eric Mendelsohn, President, and CEO, Kevin Pascoe, Chief Investment Officer, John Spaid, Chief Financial Officer, and David Travis, Chief Accounting Officer. The results, as well as notice of the accessibility of this conference call on a listen-only basis, were released after the market closed yesterday in a press release that's been covered by the financial media. As a reminder, any statements in this conference call which are not historical facts are forward-looking statements. NHI cautions investors that any forward-looking statements may involve risks or uncertainties and are not guarantees of future performance. All forward-looking statements represent NHI's judgment as of the date of this conference call.

Investors are urged to carefully review various disclosures made by NHI and its periodic reports filed with the Securities and Exchange Commission, including the risk factors and other information disclosed in NHI's Form 10-Q for the quarter ended March 31, 2022. Copies of these filings are available on the SEC's website at sec.gov or on NHI's website at nhireit.com. In addition, certain terms used in this call are non-GAAP financial measures, reconciliations of which are provided in NHI's earnings release and related tables and schedules, which have been filed on Form 8-K with the SEC. Listeners are encouraged to review those reconciliations provided in the earnings release together with other information provided in that release. I'll now turn the call over to our CEO, Eric Mendelsohn.

Eric Mendelsohn
President and CEO, National Health Investors

Thank you, Dana. Hello, and thanks for joining us today. It has been one year since we communicated our initial plans to optimize our portfolio through $250 million-$400 million of asset dispositions, lease restructurings with operators where we have confidence in their ability to recover, and tenant transitions to new and existing partners, including SHOP joint ventures. We've accomplished a great deal in the past year. We have completed approximately $262 million in asset sales since that time, including $214 million in sales of underperforming senior housing properties. We expect to complete dispositions exceeding $100 million in net proceeds of several other underperforming properties in the first half of this year. These dispositions will have minimal impact on our cash NOI as the properties aren't contributing much rental income.

We restructured the Bickford lease effective April 1st, which is consistent with the plan that we communicated in November. Bickford is a valued partner to NHI, and we're confident that our new leases create a more sustainable relationship that improves our coverage, generates excess cash flow that can be used to repay NHI's deferral balance, and provides more capital for Bickford to reinvest and maintain our buildings. Recall that we have a fair market value reset after two years on the rent, so their success will be our success as well. We reached another great milestone for our company as we transitioned the remaining legacy Holiday properties into two new SHOP ventures with Merrill Gardens and Discovery Senior Living in April. While it's still early stages, we've been pleased with the transition so far and look forward to providing much more detail on these ventures in our second quarter report.

These types of ventures, coupled with our traditional triple net strategy, make NHI a formidable competitor for new business in senior housing. The balance sheet is in great shape as we reduced debt by over $275 million in the last 12 months and maintained leverage within our target of 4x-5 x net debt to adjusted EBITDA despite significant deferrals and non-payment from Welltower for eight months. The pipeline is starting to rebuild, and we recently announced a $240 million share repurchase plan, so we see plenty of near-term opportunity to deploy capital without the need to issue equity. We included a new slide in our supplemental that outlines the activity undertaken in our portfolio optimization. I'd describe the slide as busy, and this is intentional.

We knew the process would introduce volatility to our cash flow and that there would be unforeseen obstacles that we'd have to navigate along the way. We've tried to communicate our plan through regular business updates, but understand that the many moving pieces made for difficult forecasting. Our operators continue to deal with operational challenges. However, we feel like we're in a better position now to forecast these challenges. We are now happy to report that we've largely completed portfolio optimization and reached an inflection point which has greatly improved our visibility. As a result, we recently issued guidance, which John will discuss in more detail in his review of our quarter results. John?

John Spaid
CFO, National Health Investors

Thank you, Eric, and good day, everyone. Beginning with our net income for diluted common share. For the first quarter ending March 31, 2022, we achieved $0.18 compared to $0.78 for the same period in 2021, and sequentially up $0.4 from the fourth quarter in 2021. There are a number of items that impacted our first quarter results, which are outlined in our earnings press release. For our FFO metrics per diluted common share for the first quarter ending March 31, 2022, sequentially compared to the fourth quarter, Nareit FFO decreased $0.2- $1.05 from $1.07, and normalized FFO increased $0.4 from $1.06 to $1.10. Sequentially, for the first quarter, our normalized funds available for distribution increased $6.8 million from the fourth quarter.

The sequential quarterly increase in FAD was largely driven by the recognition of the $8.8 million Holiday lease deposit, which we've previously discussed, and lower interest expense. This was offset by additional rent concessions, previously announced lease modifications, dispositions, and higher legal expense. The results we achieved for the first quarter are in line with the midpoint of our recently issued guidance for 2022. Reconciliations for our pro forma performance metrics can be found in our earnings release and 10-Q filed yesterday at sec.gov. Our first quarter dividend of $0.90 per share was paid on May 6, 2022, and represents normalized FFO and FAD total dollar payout ratios of 81.9% and 78.3% respectively.

As announced yesterday, our board declared our second quarter dividend of $0.90 per share for shareholders of record on June 30 and payable on August 5. Turning to the balance sheet for the quarter ending March 31, we reduced our debt by approximately $275.7 million since the end of the first quarter of 2021. Our net debt to adjusted EBITDA leverage ratio was 4.9 x. Please keep in mind that our Q1 leverage ratio is not adjusted for the seasonally higher first quarter non-cash stock option expense. While still within our stated financial policies, we expect to see immediate improvement in our leverage ratios as we have transitioned the legacy Holiday portfolio to new operators and recommenced receiving NOI from those facilities.

We recast our revolving credit facility during the first quarter and increased the available credit to $700 million from $550 million. On April 30, we had $85 million outstanding under the revolver and $16.4 million in cash. We did not issue any equity during our ATM program during the first quarter and do not expect to issue equity during the second quarter. We continue to have approximately $416 million available to us under our ATM program, as well as $240 million remaining under our recent stock buyback program.

On April 18th, we issued annual guidance, which includes NAREIT FFO per share in a range of $4.32-$4.42, normalized FFO per share in a range of $4.38-$4.48, and FAD in a range of $201.8 million-$206.4 million.

Our 2022 guidance includes $8.8 million in rent from the Holiday lease deposit recognition during the first quarter, $6.9 million from a settlement payment related to the Welltower lawsuit, $76 million in investment funding on existing commitments, NOI commencing from our SHOP portfolio beginning April 1 based upon assumptions consistent with amounts communicated in prior calls, and rent concessions, asset dispositions, and loan repayments throughout 2022, including the repayment of an existing $111 million, 7.35% loan at the end of the second quarter. Our guidance does not assume any benefit from future unannounced acquisitions or any repayment on outstanding deferral balances. Other assumptions can be found in the April press release. With that, I'll now turn the call over to Kevin Pascoe to discuss our portfolio. Kevin?

Kevin Pascoe
CIO, National Health Investors

Thank you, John. I'll concentrate my comments on our major asset classes and operators, as well as business development and pipeline activity. Starting with our senior housing needs-driven portfolio of 92 properties. This group has experienced the most disruption from the pandemic and has been where most of our portfolio optimization efforts are focused. As Eric noted, we completed approximately $214 million in senior housing dispositions and have restructured a couple of leases with large tenants, including Bickford. We restructured the Bickford lease on schedule with annualized rent for the portfolio set at $28 million. On a trailing three-month basis, the portfolio's lease coverage is above 1x, and we expect that to trend higher as sales and leads have been improving.

We are still in the process of selling some Bickford buildings, which will improve cash flow to the enterprise and lessen the need for future assistance. That said, we did not provide any rent concessions for Bickford in April, and we are not forecasting any concession for May. We are determining the appropriate level of repayment for their deferral balance and are targeting a minimum repayment of $3 million annually, with reductions of up to $6 million contingent on Bickford meeting specific performance targets and completing certain property dispositions. On April 1st, we transitioned six legacy Holiday properties to Merrill Gardens and nine properties to Discovery Senior Living, both of which are joint ventures under our senior housing operating model, or SHOP.

Transitions are generally disruptive, but we are optimistic based on early results and feel confident that the annualized NOI contribution will be in the low to mid-teens, with future incremental upside of $6 million-$8 million. The 13 CCRCs in our portfolio, which account for 30% of our annualized cash revenue net of deferrals, have performed great. SLC, our largest tenant, had EBITDARM coverage of 1.18 x, which actually was an increase from 1.1 x in the prior period when excluding PPP loans. Coverage in our other CCRCs declined year-over-year, but was still comfortable at approximately 1.57 x.

The skilled nursing portfolio, which represents 35% of annualized cash revenue net of deferrals, continues to have solid EBITDARM coverage at 2.71x , including 3.61 x at NHC and approximately 1.9 x for other operators. SNF's resilience is primarily attributable to NHC and Ensign, which represent approximately 75% of the SNF portfolio. Our other SNF 5 operators under leases have received minimal rent concessions since the pandemic began, and we did not provide any assistance in April. We are hopeful that CMS's final reimbursement rule is more favorable than the proposed rule, but we still don't expect the overall health of our SNF operators to materially change if that is not the case.

Regarding recent business development, we announced a new construction loan with Encore Senior Living for $28.5 million in the first quarter and just exercised our purchase option with Encore for a 53-unit AL memory care property in Wisconsin for $13.3 million. We also transitioned three properties in Illinois that were under NOI-based leases to Encore under a 15-year master lease, which will see rent ratchet up to $1.5 million annually starting in year three. We funded $3.4 million net under our mezzanine loan with Montecito during the quarter, bringing the total balance to $15.8 million on the $50 million commitment. We are starting to see an improvement in the pipeline, including shorter-term financing deals and to a lesser extent, longer-term triple net lease deals as we'd still characterize the current environment as a seller's market.

We are seeing more RIDEA-type opportunities following our announcement on the Merrill Gardens and Discovery joint ventures. While we see these structures as another avenue for growth in the senior housing industry, the near-term focus is on investments in our own organization to ensure we have resources in place that will make SHOP a steady NOI contributor. Said another way, we need to make sure we get these joint ventures right before looking to expand the platform. With that, I'll hand the call back over to Eric.

Eric Mendelsohn
President and CEO, National Health Investors

Thank you, Kevin. We're grateful to be turning the page on this chapter of our history as we look to take advantage of our strong financial position to reignite our growth rate. Before turning the call over to Q&A, I'd like to welcome Tracy Colden as the newest addition to NHI's board of directors, which she will be joining on June first. We conducted a nationwide search, and Tracy really stood out as the best fit, and we are really pleased to have her unique perspective in the boardroom. Operator, we'll now open the line for questions.

Operator

Thank you. If you'd like to register for a question, please press one followed by four on your telephone. You will hear a three-tone prompt to acknowledge your request. If your question has been answered and you would like to withdraw your registration, please press one followed by three. Once again, that's one-four to register for a question. One brief moment for the first question. Our first question is from the line of Rich Anderson with SMBC. Please go ahead. Your line's open.

Rich Anderson
Managing Director and Senior REIT Analyst, SMBC

Thanks. Good morning. On the Bickford buyout or payback of the deferrals, just so I understand, it's $3 million a year, but on a monthly installment up to a total of $3 million per year at a minimum. Is that the right way to think about it?

Kevin Pascoe
CIO, National Health Investors

Hey, Rich, it's Kevin. That's the right way to think about it. What we're looking at right now is the kind of the formula and timing of the payments. As they continue to increase performance, they will have a minimum payback, and then, to the extent they're doing better than that, they'll be paying more. For now, what we're targeting is that $3 million annually number.

Rich Anderson
Managing Director and Senior REIT Analyst, SMBC

Okay. For the first quarter, you said $9.8 million in concessions, and maybe this is similar, but can you define concessions? Are those all deferrals or a combination of deferrals and abatements? Maybe you could just clarify that, or is that just the Bickford restructure? I'm just.

Eric Mendelsohn
President and CEO, National Health Investors

Yes.

Rich Anderson
Managing Director and Senior REIT Analyst, SMBC

Define that more.

John Spaid
CFO, National Health Investors

Hey, Rich, this is John. It's both. Roughly, you can see it in page 20 of our supplemental.

Rich Anderson
Managing Director and Senior REIT Analyst, SMBC

Okay.

John Spaid
CFO, National Health Investors

It is both.

Rich Anderson
Managing Director and Senior REIT Analyst, SMBC

If it's there, then I could find it myself.

John Spaid
CFO, National Health Investors

Yeah.

Rich Anderson
Managing Director and Senior REIT Analyst, SMBC

Okay. 79.7% collection in the first quarter, 94.1% collection in April. Can you reconcile that for me again, you know, would we expect the second quarter to average to something well below 94.1% as the month plays itself out? Just any clarification there.

John Spaid
CFO, National Health Investors

Sure. This is John again. Hopefully not. What you're seeing there are some of the effects from the adjustments we're making to long-term leases. As we do that, you know, obviously, collections should improve unless we have, you know, additional deferrals or abatements that we didn't expect. That's the way I would think about it, characterize it.

Rich Anderson
Managing Director and Senior REIT Analyst, SMBC

Okay. Last for me. You know, recognizing the Bickford restructure, and all the work that went into that, what is the magic behind four master leases? And was there any thought to simplifying the Bickford relationship and sort of consolidating into something like one master lease? Or is there some real benefit to breaking them out into four separate ones? Thanks.

John Spaid
CFO, National Health Investors

Well, let me take it initially because one reason is we have some of the properties secured by debt, and the requirement there is to separate those properties into a different lease structure. I'll turn it back over to Kevin for the rest of it.

Kevin Pascoe
CIO, National Health Investors

Sure. I mean, the big part that John hit on already is these had different elements of debt to them over time, which NHI is working on. There was HUD originally, there's Fannie Mae debt on some. And then part of it's just a function of acquiring different portfolios over time. Yes, there is consideration given to reducing it down. We're still working through some pieces with them, but simplification is always a priority for us. That would still be on the table in the future. For now, we're keeping them in their buckets, partly for debt reasons, but partly just to kind of keep things status quo while we work through the issues.

Once we kind of get to the end and have a recasting of the relationship, when we do a fair market, that would be, likely something we'll have on the table.

Rich Anderson
Managing Director and Senior REIT Analyst, SMBC

Okay. Kevin, maybe just one quick one for you. Expanding RIDEA now that you've gotten, you know, the Holiday transitions done, you know, what percentage of your SHOP. What percentage of your senior housing portfolio appears at least a potential for a conversion from triple net lease to RIDEA? You know, what's the opportunity set there?

Kevin Pascoe
CIO, National Health Investors

Well, I would say we've looked at it more from a new business perspective than we have from a conversion perspective to date. That's not to take it off the table. If there's a good opportunity for NHI to capture some upside, we will absolutely have those conversations. I think about it more as a tool in the tool belt from a acquisition and relationship building perspective at this point in time.

Rich Anderson
Managing Director and Senior REIT Analyst, SMBC

Okay. Fair enough. Thanks very much.

Operator

We have a question from Austin Wurschmidt with KeyBanc Capital Markets. Please go ahead. Your line's open.

Austin Wurschmidt
Senior Equity Research Analyst, KeyBanc Capital Markets

Great. Thank you. You guys mentioned for the 15 Holiday assets that were transitioned to reach kind of that low- to mid-teens NOI range, annualized, I believe. What was the quarterly run rate, you know, for those assets, the quarterly NOI for those assets in the first quarter? And what are you assuming in guidance that that ramps to by the end of this year?

John Spaid
CFO, National Health Investors

I guess I'll take that one. This is John. We haven't really given you that information about the first quarter. There was a lot of noise in the first quarter. I don't know that would be a meaningful number to provide you. For the second quarter, though, which is more meaningful, what you'll see is roughly along that run rate that you just mentioned. However, it'll be somewhat staggered because there'll be a little bit of transition effects in the second quarter. But we clearly see it ramping in the third and fourth quarter to get to that number that we've been talking about that you just mentioned. I hope that helps.

Austin Wurschmidt
Senior Equity Research Analyst, KeyBanc Capital Markets

No, that is helpful. As you look to restructure these deals, I don't know if this has been provided or not, but are the management fees, you know, are you basing those on revenue or NOI with these new operator relationships?

Kevin Pascoe
CIO, National Health Investors

This is Kevin. The management fees are based on just revenue, and it's a typical market management fee. What we've done with these is create a joint venture where they participate in the upside, but it's not through a management fee structure. It's more through an earn-out and, you know, valuation of the property over time, plus sharing of cash flow down the road. That's as a function of their co-invest, not just the management of the building.

Austin Wurschmidt
Senior Equity Research Analyst, KeyBanc Capital Markets

Got it. That's helpful. Just maybe talking a little bit about, you know, the investment backlog. You mentioned it's starting to build. Any sense on sort of timing or volume as we think about sort of match funding that with the dispositions, and then how the investment backlog breaks down maybe by product type that you know that you're targeting?

Kevin Pascoe
CIO, National Health Investors

Sure. This is Kevin again. We remain opportunistic, and I think that's just how NHI has been in the past, is we continue to work relationships and see where opportunities come up and where that marries up. To be able to match fund, it would be amazing. Frankly, that's not always how deal flow works. It's a little more choppy, and I would still characterize. Like I said in my prepared comments, that it's still a bit of a choppy market. We are starting to see some more deal flow, as you say, looking at various opportunities on both the equity and debt side. We did close on a couple deals with Encore, so again, making some inroads and servicing our existing relationships, and we still have commitments to fund throughout the year.

You'll still see a reasonably steady level of investment by NHI, servicing those existing commitments, and then we're still looking for new opportunities, but we're being patient there.

Austin Wurschmidt
Senior Equity Research Analyst, KeyBanc Capital Markets

Thanks for the time.

Operator

Once again, as a reminder, if you'd like to register for a question, please press one one-four on your telephone. We do have a question from Omotayo Okusanya with Mizuho. Please go ahead. Your line's open.

Omotayo Okusanya
Managing Director, Mizuho

Yes. Good afternoon, everyone. Just a couple from me. Hey, guys. Bickford, I don't know if you can share any more details just around the formulation that helps to determine what the monthly minimum payments will be. I mean, just kinda give us a very high level of how you kind of determine that, you know, with them. Also exactly what circumstances they get kind of that $6 million credit of the $26 million of deferrals that are still out there.

Kevin Pascoe
CIO, National Health Investors

Sure, Tayo. It's Kevin. From the incentives perspective, it's really around incentivizing them to do things that we would like to see that organization get to. You know, very broad strokes, it's around at an enterprise level, getting to a portfolio occupancy. It's getting to a portfolio margin. It's being able to complete some of these dispositions that we've been working on. There's some we have some purchase options with them, so there's some discussion around how those get treated and maybe some a win-win or a shared appreciation scenario as it relates to some of those buildings. NHI gets a good purchase price, and they get some relief. There's a few things that we're talking about there that would be really help everybody.

on the formulation of the payback, you know, that's really what we're saying is that's what we're working on now is when does those minimum payments start? What does the formula look like? We have all of it sketched out in terms of what the formula looks like based on the production of NOI from NHI's portfolio subset and how that gets paid over. What we're really looking at is the pro forma, the lease-up schedule, and when the hard minimum payments would come up and what those bullets might look like, 'cause we wanna make sure we do it thoughtfully, where we're not getting back into a place where we're having to recast anything.

Omotayo Okusanya
Managing Director, Mizuho

Gotcha.

Kevin Pascoe
CIO, National Health Investors

I would tell you that through the first quarter, you know, with some of the late winter COVID spikes and some of the labor issues that we're seeing in the marketplace, that moved the goalposts a bit for a lot of operators in terms of how they're thinking about leasing back up and when NOI stabilizes. Again, we're just trying to be mindful of that and thoughtful how we set the schedule, so we don't have to keep revisiting it.

Omotayo Okusanya
Managing Director, Mizuho

Gotcha. Okay. That's helpful. The $1.3 million of deferrals in April to the three operators, was any of that to a new operator at all?

John Spaid
CFO, National Health Investors

Tayo, this is John. To a new operator that hadn't been talked about in the past, no.

Omotayo Okusanya
Managing Director, Mizuho

Got it.

John Spaid
CFO, National Health Investors

I would say that some of those operators, you know, are more recent sort of phenomenon and are, you know, we've got more work to do. But we're down to, let's just call it, the last 10%-15% of our optimization strategy.

Omotayo Okusanya
Managing Director, Mizuho

Okay. That's helpful. Last one for me, if you don't mind. Again, just with rising rates, again, we get the EBITDA rent coverages, which is helpful, but given that we don't really know the capital structure of a lot of the tenants, I mean, are there any tenants where, again, rising rates start to cause a real issue because they have a bunch of debt maturing, or they have high leverage? Just anything like that may be on your radar screen that suddenly puts someone on your watch list?

Kevin Pascoe
CIO, National Health Investors

Tayo, it's Kevin again. That's a conversation that we have with all of our customers, and we try to make sure we're talking to them at least quarterly, if not monthly, for even the people that aren't being discussed time and time again here. To our knowledge, there's not any significant maturities or debt recaps that are happening in the portfolio that would negatively affect the credit behind our customers. It is a topic and something we're mindful of.

Omotayo Okusanya
Managing Director, Mizuho

Great. Thank you very much.

Operator

There are no further questions at this time.

John Spaid
CFO, National Health Investors

Thanks, everyone, for your interest, and we'll see you in person at Nareit in a couple of weeks.

Operator

That concludes the call for today. We thank you for your participation. I ask that you please disconnect your lines.

Powered by